Julie Putnam serves as the controller at Sorriso Pharmaceuticals. She brings over 17 years of biotech industry experience where she has been involved in the sale of four companies and two public offerings. Previously, Julie served as controller for Lengo Therapeutics (acquired by Blueprint Medicines) and controller and accounting manager of Amplyx Pharmaceuticals (acquired by Pfizer). She has also provided accounting consulting services to various biotech companies including Lumena Pharmaceuticals, Reneo Pharmaceuticals, Mirum Pharmaceuticals, Curzion Pharmaceuticals and Brain Cells. She began her career at Ernst & Young in San Diego where she held roles as an auditor and office director of human resources. Julie holds a Bachelor of Accountancy from the University of San Diego.